As on Thursday, Wave Life Sciences Ltd (NASDAQ: WVE) started slowly as it slid -0.86% to $13.82, before settling in for the price of $13.94 at the close. Taking a more long-term approach, WVE posted a 52-week range of $5.28-$21.73.
The Healthcare sector firm’s twelve-monthly sales growth has been 34.27% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 34.27%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -67.25%. This publicly-traded company’s shares outstanding now amounts to $160.29 million, simultaneously with a float of $150.84 million. The organization now has a market capitalization sitting at $2.53 billion.
Wave Life Sciences Ltd (WVE) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Wave Life Sciences Ltd’s current insider ownership accounts for 17.57%, in contrast to 75.38% institutional ownership. According to the most recent insider trade that took place on Jan 02 ’26, this organization’s insider sold 9,375 shares at the rate of 16.03, making the entire transaction reach 150,260 in total value, affecting insider ownership by 25,000. Preceding that transaction, on Dec 11 ’25, Company’s 10% Owner bought 1,470,000 for 19.00, making the whole transaction’s value amount to 27,930,000. This particular insider is now the holder of 18,245,691 in total.
Wave Life Sciences Ltd (WVE) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
Wave Life Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -67.25% and is forecasted to reach -1.22 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -18.16% through the next 5 years, which can be compared against the 34.27% growth it accomplished over the previous five years trading on the market.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Let’s observe the current performance indicators for Wave Life Sciences Ltd (WVE). It’s Quick Ratio in the last reported quarter now stands at 2.51. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 23.15.
In the same vein, WVE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.75, a figure that is expected to reach -0.27 in the next quarter, and analysts are predicting that it will be -1.22 at the market close of one year from today.
